The global prenatal genetic counselling market is estimated to increase rapidly over the forecast period. Historically, genetic counselling support services were mostly provided in settings such as indicated risk assessment and other prenatal/preconception segments and pediatric risk care. On the other hand, pharmacogenomics and diagnostic counselling services have become an important element of contemporary diagnostic and treatment practices, especially with the emergence of new companies in the genetic counselling industry. Hence, this will lead to the high demand for prenatal genetic counselling.
Frequently Asked Questions
The market is segmented based on Segmentation, By Type (Predictive Testing, Carrier Testing, Prenatal and Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, Others), Technology (Cytogenetic Testing, Biochemical Testing, Molecular Testing), Application (Chromosome Analysis, Genetic Disease Diagnosis, Cardiovascular Disease Diagnosis, Others) – Industry Trends and Forecast to 2032
.
The Global Prenatal Genetic Counselling Market size was valued at USD 1.66 USD Billion in 2024.
The Global Prenatal Genetic Counselling Market is projected to grow at a CAGR of 11.5% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
